Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patients (English)
- New search for: Cho, Y. Y.
- New search for: Lee, J.‐H.
- New search for: Chang, Y.
- New search for: Nam, J. Y.
- New search for: Cho, H.
- New search for: Lee, D. H.
- New search for: Cho, E. J.
- New search for: Yu, S. J.
- New search for: Lee, J. M.
- New search for: Kim, Y. J.
- New search for: Yoon, J.‐H.
- New search for: Cho, Y. Y.
- New search for: Lee, J.‐H.
- New search for: Chang, Y.
- New search for: Nam, J. Y.
- New search for: Cho, H.
- New search for: Lee, D. H.
- New search for: Cho, E. J.
- New search for: Yu, S. J.
- New search for: Lee, J. M.
- New search for: Kim, Y. J.
- New search for: Yoon, J.‐H.
In:
Journal of Viral Hepatitis
;
25
, 10
;
1161-1171
;
2018
- Article (Journal) / Electronic Resource
-
Title:Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patients
-
Contributors:Cho, Y. Y. ( author ) / Lee, J.‐H. ( author ) / Chang, Y. ( author ) / Nam, J. Y. ( author ) / Cho, H. ( author ) / Lee, D. H. ( author ) / Cho, E. J. ( author ) / Yu, S. J. ( author ) / Lee, J. M. ( author ) / Kim, Y. J. ( author )
-
Published in:Journal of Viral Hepatitis ; 25, 10 ; 1161-1171
-
Publisher:
-
Publication date:2018-10-01
-
Size:11 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 25, Issue 10
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1107
-
Issue Information| 2018
- 1110
-
Transplanting organs from hepatitis B positive donors: Is it safe? Is it ethical?Anwar, Nadeem / Sherman, Kenneth E. et al. | 2018
- 1116
-
Hepatitis B virus infection in Taiwan: The role of NTCP rs2296651 variant in relation to sexNfor, O. N. / Wu, M.‐F. / Debnath, T. / Lee, C.‐T. / Lee, W. / Liu, W.‐H. / Tantoh, D. M. / Hsu, S.‐Y. / Liaw, Y.‐P. et al. | 2018
- 1121
-
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co‐infected patients from Western AfricaBoyd, A. / Moh, R. / Maylin, S. / Abdou Chekaraou, M. / Mahjoub, N. / Gabillard, D. / Anglaret, X. / Eholié, S. P. / Delaugerre, C. / Danel, C. et al. | 2018
- 1132
-
Detection of in vivo hepatitis B virus surface antigen mutations—A comparison of four routine screening assaysGencay, M. / Seffner, A. / Pabinger, S. / Gautier, J. / Gohl, P. / Weizenegger, M. / Neofytos, D. / Batrla, R. / Woeste, A. / Kim, H. S. et al. | 2018
- 1139
-
Serum NGAL can act as an early renal safety biomarker during long‐term nucleos(t)ide analogue antiviral therapy in chronic hepatitis BCarey, I. / Byrne, R. / Childs, K. / Horner, M. / Bruce, M. / Wang, B. / Dusheiko, G. / Agarwal, K. et al. | 2018
- 1151
-
A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis BWang, J. / Xia, J. / Zhang, R. / Yan, X. / Yang, Y. / Zhao, X. / Chang, H. / Wang, G. / Chen, G. / Liu, Y. et al. | 2018
- 1161
-
Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patientsCho, Y. Y. / Lee, J.‐H. / Chang, Y. / Nam, J. Y. / Cho, H. / Lee, D. H. / Cho, E. J. / Yu, S. J. / Lee, J. M. / Kim, Y. J. et al. | 2018
- 1172
-
Systematic review and meta‐analysis: Development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis e antigen seroconversionZhou, T.‐C. / Lai, X. / Feng, M.‐H. / Tang, Y. / Zhang, L. / Wei, J. et al. | 2018
- 1180
-
Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infectionMartinello, M. / Bhagani, S. / Gane, E. / Orkin, C. / Cooke, G. / Dore, G. J. / Petoumenos, K. / Applegate, T. L. / Tu, E. / Marks, P. et al. | 2018
- 1189
-
Early development of de novo hepatocellular carcinoma after direct‐acting agent therapy: Comparison with pegylated interferon‐based therapy in chronic hepatitis C patientsYoo, S. H. / Kwon, J. H. / Nam, S. W. / Kim, H. Y. / Kim, C. W. / You, C. R. / Choi, S. W. / Cho, S. H. / Han, J.‐Y. / Song, D. S. et al. | 2018
- 1197
-
Effectiveness and cost‐effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of FranceCousien, A. / Tran, V. C. / Deuffic‐Burban, S. / Jauffret‐Roustide, M. / Mabileau, G. / Dhersin, J.‐S. / Yazdanpanah, Y. et al. | 2018
- 1208
-
Epidemiological characteristics and associated factors of acute hepatitis A outbreak among HIV‐coinfected men who have sex with men in Taiwan, June 2015‐December 2016Cheng, C.‐Y. / Wu, H.‐H. / Zou, H. / Lo, Y.‐C. et al. | 2018
- 1216
-
Younger age and language barriers are associated with nonadherence to clinical follow‐up in hepatitis B treatmentChi, H. / Japhary, A. / de Man, R. A. / de Knegt, R. J. / Janssen, H. L. A. / Hansen, B. E. et al. | 2018
- 1220
-
Is revaccination required in children who received a full primary vaccination against hepatitis B in infancy? A letter in response to Changes and analysis of anti‐HBs titres after primary immunization in 1‐to 16‐year‐old Chinese children: A hospital‐based studyZhou, Y. / Zhou, Y.‐H. et al. | 2018
- 1221
-
Response to letter to the editor: Is revaccination required in children who received a full primary vaccination against hepatitis B in infancy?! A response letter from the authors of Changes and analysis of anti‐HBs titres after primary immunization in 1‐to 16‐year‐old Chinese children: A hospital‐based studyYue, Xiaomei / Yang, Yuting / Zhao, Yao et al. | 2018